257 related articles for article (PubMed ID: 25599612)
61. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
[TBL] [Abstract][Full Text] [Related]
62. Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity.
Iñiguez G; Soto N; Avila A; Salazar T; Ong K; Dunger D; Mericq V
J Clin Endocrinol Metab; 2004 Nov; 89(11):5500-3. PubMed ID: 15531504
[TBL] [Abstract][Full Text] [Related]
63. Circulating follistatin in the human foetus at term birth.
Sebastiani G; Díaz M; López-Bermejo A; Arranz A; de Zegher F; Ibáñez L
Pediatr Obes; 2012 Feb; 7(1):39-43. PubMed ID: 22434738
[TBL] [Abstract][Full Text] [Related]
64. Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading.
Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Pongratanakul S; Poomthavorn P
Clin Endocrinol (Oxf); 2015 Dec; 83(6):820-7. PubMed ID: 25929297
[TBL] [Abstract][Full Text] [Related]
65. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
[TBL] [Abstract][Full Text] [Related]
66. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
[TBL] [Abstract][Full Text] [Related]
67. Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia.
Dekker Nitert M; Scholz-Romero K; Kubala MH; McIntyre HD; Callaway LK; Barrett HL
Reprod Biol Endocrinol; 2015 Mar; 13():14. PubMed ID: 25890271
[TBL] [Abstract][Full Text] [Related]
68. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA).
Arends NJ; Boonstra VH; Duivenvoorden HJ; Hofman PL; Cutfield WS; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2005 Jan; 62(1):44-50. PubMed ID: 15638869
[TBL] [Abstract][Full Text] [Related]
69. Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease.
Marchelek-Mysliwiec M; Dziedziejko V; Dolegowka K; Pawlik A; Safranow K; Stepniewska J; Wisniewska M; Malyszko J; Ciechanowski K
J Appl Biomed; 2020 Aug; 18(2-3):61-69. PubMed ID: 34907727
[TBL] [Abstract][Full Text] [Related]
70. [Changes in circulating levels of adiponectin and leptin in children during the first two years of life].
Strocchio L; Bozzola E; Cerbo RM; Meazza C; Travaglino P; Pagani S; Laarej K; Stronati M; Bozzola M
Minerva Pediatr; 2007 Dec; 59(6):739-44. PubMed ID: 17978782
[TBL] [Abstract][Full Text] [Related]
71. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
[TBL] [Abstract][Full Text] [Related]
72. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS
Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274
[TBL] [Abstract][Full Text] [Related]
73. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
[TBL] [Abstract][Full Text] [Related]
74. The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth.
Meral C; Cekmez F; Pirgon O; Asya Tanju I; Metin Ipcioglu O; Karademir F; Gocmen I
J Matern Fetal Neonatal Med; 2011 Jan; 24(1):166-70. PubMed ID: 20486883
[TBL] [Abstract][Full Text] [Related]
75. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans.
Kralisch S; Tönjes A; Krause K; Richter J; Lossner U; Kovacs P; Ebert T; Blüher M; Stumvoll M; Fasshauer M
J Endocrinol; 2013 Feb; 216(2):135-43. PubMed ID: 23129782
[TBL] [Abstract][Full Text] [Related]
76. Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age.
de Kort SW; van Doorn J; van de Sande AG; Leunissen RW; Hokken-Koelega AC
J Clin Endocrinol Metab; 2010 Feb; 95(2):864-71. PubMed ID: 20061427
[TBL] [Abstract][Full Text] [Related]
77. Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.
Li JR; Chiu KY; Ou YC; Wang SS; Chen CS; Yang CK; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chen CJ
Biofactors; 2019 Jan; 45(1):62-68. PubMed ID: 30334297
[TBL] [Abstract][Full Text] [Related]
78. The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review.
Sadowska A; Poniedziałek-Czajkowska E; Mierzyński R
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139126
[TBL] [Abstract][Full Text] [Related]
79. Circulating GLP-1 in infants born small-for-gestational-age: breast-feeding versus formula-feeding.
Díaz M; Bassols J; Sebastiani G; López-Bermejo A; Ibáñez L; de Zegher F
Int J Obes (Lond); 2015 Oct; 39(10):1501-3. PubMed ID: 26088812
[TBL] [Abstract][Full Text] [Related]
80. Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth.
Evagelidou EN; Giapros VI; Challa AS; Kiortsis DN; Tsatsoulis AA; Andronikou SK
Eur J Endocrinol; 2007 Feb; 156(2):271-7. PubMed ID: 17287418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
